A variable number of tandem repeats polymorphism in an E2F-1 binding element in the 5′ flanking region of SMYD3 is a risk factor for human cancers

Nature Genetics

Volumn 37, Issue 10, 2005, Pages 1104-1107

  Tsuge, Masataka ^a,b   Hamamoto, Ryuji ^a   Silva, Fabio Pittella ^a   Ohnishi, Yozo ^c   Chayama, Kazuaki ^b   Kamatani, Naoyuki ^d   Furukawa, Yoichi ^a   Nakamura, Yusuke ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR E2F1;

ALLELE; ARTICLE; BREAST CARCINOMA; CANCER; CANCER RISK; CARCINOGENESIS; CELL GROWTH; COLORECTAL CARCINOMA; CONTROLLED STUDY; DNA FLANKING REGION; GENE; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN BINDING; RISK FACTOR; SMYD3 GENE; TANDEM REPEAT; UPREGULATION;

5' FLANKING REGION; ALLELES; BASE SEQUENCE; E2F1 TRANSCRIPTION FACTOR; GENETIC PREDISPOSITION TO DISEASE; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASMS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RISK FACTORS; TANDEM REPEAT SEQUENCES; TUMOR CELLS, CULTURED;

EID: 27144496194     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng1638     Document Type: Article

References (22)

1. Hamamoto, R. et al. SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells. Nat. Cell Biol. 6, 731-740 (2004).
2. Boggs, B.A. et al. Differentially methylated forms of histone H3 show unique association patterns with inactive human X chromosomes. Nat. Genet. 30, 73-76 (2002).
3. Litt, M.D., Simpson, M., Gaszner, M., Allis, C.D. & Felsenfeld, G. Correlation between histone lysine methylation and developmental changes at the chicken beta-globin locus. Science 293, 2453-2455 (2001).
4. Schneider, R. et al. Histone H3 lysine 4 methylation patterns in higher eukaryotic genes. Nat. Cell Biol. 6, 73-77 (2004).
5. Bernstein, B.E. et al. Methylation of histone H3 Lys 4 in coding regions of active genes. Proc. Natl. Acad. Sci. USA 99, 8695-8700 (2002).
6. Bell, L.A. & Ryan, K.M. Life and death decisions by E2F-1. Cell Death Differ. 11, 137-142 (2004).
7. Black, A.R. & Azizkhan-Clifford, J. Regulation of E2F: a family of transcription factors involved in proliferation control. Gene 237, 281-302 (1999).
8. Stevaux, O. & Dyson, N.J. A revised picture of the E2F transcriptional network and RB function. Curr. Opin. Cell Biol. 14, 684-691 (2002).
9. Phillips, A.C. & Vousden, K.H. E2F-1 induced apoptosis. Apoptosis 6, 173-182 (2001).
10. Dyson, N. The regulation of E2F by pRB-family proteins. Genes Dev. 12, 2245-2262 (1998).
11. Harbour, J.W. & Dean, D.C. The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev. 14, 2393-2409 (2000).
12. Spire-Vayron de la Moureyre, C. et al. Characterization of a variable number tandem repeat region in the thiopurine S-methyltransferase gene promoter. Pharmacogenetics 9, 189-198 (1999).
13. Nakamura, Y., Carlson, M., Krapcho, K., Kanamori, M. & White, R. New approach for isolation of VNTR markers. Am. J. Hum. Genet. 43, 854-859 (1988).
14. Nakamura, Y., Koyama, K. & Matsushima, M. VNTR (variable number of tandem repeat) sequences as transcriptional, translational, or functional regulators. J. Hum. Genet. 43, 149-152 (1998).
15. Nakamura, Y. et al. Variable number of tandem repeat (VNTR) markers for human gene mapping. Science 235, 1616-1622 (1987).
16. Zehbe, I., Voglino, G., Wilander, E., Genta, F. & Tommasino, M. Codon 72 polymorphism of p53 and its association with cervical cancer. Lancet 354, 218-219 (1999).
17. Bond, G.L. et al. A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell 119, 591-602 (2004).
18. Cai, Q. et al. Association of breast cancer risk with a GT dinucleotide repeat polymorphism upstream of the estrogen receptor-alpha gene. Cancer Res. 63, 5727-5730 (2003).
19. Krippl, P. et al. The 5A/6A polymorphism of the matrix metalloproteinase 3 gene promoter and breast cancer. Clin. Cancer Res. 10, 3518-3520 (2004).
20. De Vivo, I., Hankinson, S.E., Colditz, G.A. & Hunter, D.J. A functional polymorphism in the progesterone receptor gene is associated with an increase in breast cancer risk. Cancer Res. 63, 5236-5238 (2003).
21. Okabe, H. et al. Involvement of PEG10 in human hepatocellular carcinogenesis through interaction with SIAH1. Cancer Res. 63, 3043-3048 (2003).
22. Tang, C.J., Chuang, C.K., Hu, H.M. & Tang, T.K. The zinc finger domain of Tzfp binds to the tbs motif located at the upstream flanking region of the Aie1 (aurora-C) kinase gene. J. Biol. Chem. 276, 19631-19639 (2001).